NCT00685139View on ClinicalTrials.gov

Fasting Bioavailability Study of Zonisamide Capsules

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Healthy
Interventions
DRUG

Zonisamide 100 mg Capsule

100 mg capsule administered after an overnight fast.

DRUG

Zonisamide (Zonegran®) 100 mg Capsule

100 mg capsule administered after an overnight fast.

Sponsors
All Listed Sponsors
lead

Mutual Pharmaceutical Company, Inc.

INDUSTRY

NCT00685139 - Fasting Bioavailability Study of Zonisamide Capsules | Biotech Hunter | Biotech Hunter